Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tel Aviv
SEC filing record 1 source field available
Fiscal year end
31 December
Chemomab Therapeutics Ltd. has filed 352 SEC EDGAR filings since 07 Nov 2011

SEC filing history

Showing 1-21 of 21 matching filings.

Per page
25
Current page
1
SC 13D/A File 005-86953

SC 13D/A

Filing date
29 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-86953

AMENDMENT NO. 4

Filing date
16 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-86953

AMENDMENT NO. 3

Filing date
11 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-86953

AMENDMENT NO. 2

Filing date
15 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-86953

AMENDMENT NO. 1

Filing date
05 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-86953

SC 13D/A

Filing date
17 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-86953

SC 13D

Filing date
20 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-86953

SC 13D/A

Filing date
15 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-86953

SCHEDULE 13D

Filing date
26 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-86953

SC 13D/A

Filing date
21 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-86953

SC 13D/A

Filing date
18 Dec 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-86953

SC 13D/A

Filing date
22 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-86953

SC 13D/A

Filing date
31 Mar 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-86953

SC 13D/A

Filing date
13 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-86953

SC 13D/A

Filing date
31 Dec 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-86953

SC 13D/A

Filing date
27 Jun 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-86953

PALISADE MEDICAL EQUITY I, LP

Filing date
25 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-86953

SCHEDULE 13D

Filing date
21 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-86953

SC 13D/A

Filing date
08 Jan 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-86953

SC 13D/A

Filing date
17 Dec 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-86953

SC 13D

Filing date
16 Aug 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .